Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma

Anticancer Research

Volumn 20, Issue 1 B, 2000, Pages 541-545

  Somos, Susan ^a   Farkas, Beatrix ^a  

^a NONE

Author keywords

Immunomodulation; Kaposi's sarcoma; Lymphangioma like variant; Paraproteinaemia

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 6 RECEPTOR; ISOTRETINOIN; PARAPROTEIN; RETINOIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOMODULATION; KAPOSI SARCOMA; LYMPHANGIOMA; LYMPHOCYTE FUNCTION; MALE; PARAPROTEINEMIA; PRIORITY JOURNAL; RASH; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; INTERFERON-ALPHA; ISOTRETINOIN; LYMPHANGIECTASIS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-6; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0034085964     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kaposi M: Idiopathisches multiples Pigmentsarcom der Haut. Arch Dermat Syph 4: 265-273, 1872.
2. Klein MB, Pereira FA, Kantor I: Kaposi's sarcoma complicating systemic lupus erythematosus treated with immunosuppression. Arch Dermatol 110: 602-604, 1474.
3. Penn I, Starzl TE: Malignant lymphomas in transplantation patients: A review of the world experience. Int Z Klin Pnarmakol Ther Toxicol 3: 44-54, 1970.
4. Lever WF, Schaumhurg-Lever G: Histopathology of the skin. Ed JB Lippincott Comp Philadelphia 1990.
5. Gange RW, Jones EW: Lymhangioma-like Kaposi's sarcoma Br J Dermatol 100: 327-334, 1979.
6. Palazzi D: Contributo alia sistemazione nosografica della malattia di Kaposi. Riv anat pat e one 5: 1101-1105, 1952.
7. Schaffer R, Reed M: Kaposi's Sarcoma. AMA Arch dermatol and Syph 67; 639-642, 1953.
8. Cossu S, Satta R, Cottoni F, Massarelli G: Lymphangioma-like variant of Kaposi's sarcoma: Clinicopathologic study of seven cases with review of the literature. Am J Dermatopathol 19: 16-22, 1997.
9. Masia IM, Mugoni MG, Massarelli G, et al: Lymphangioma-like pattern and anaplastic evolution in a case of classic Kaposi's sarcoma. JEADV 9: 181-184, 1997.
10. Leibowitz MR, Dagliotti M, Smith E, Murray JF: Rapidly fatal lymphangioma-like Kaposi's sarcoma. Histopathology 4: 559-999, 1980.
11. Chang Y, Cesarman E, Pessin MS et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869, 1994.
12. Schultz TF, Weiss RA: Kaposi's sarcoma. A finger on the culprit. Nature 373-317, 1995.
13. Kemeny L, Kiss M, Gyulai R et al: Herpesvirus-like nucleic acid sequences in patients with Eastern European sporadic Kaposi's sarcoma. J Invest Dermatol 106: 381, 1996.
14. Krown SE: Interferons and other biologic agents for the treatment of Kaposi's sarcoma. Hematol Oncol Clin N Am 5: 311-322, 1991.
15. Groopman JE: Biology and therapy of epidemic Kaposi's sarcoma. Cancer 59: 633-637, 1987.
16. Costa de Cunha C, Lebbé C, Rybojad M. et al: Long term follow up of non HIV Kaposi's sarcoma treated with low dose recombinant interferon alpha-2b. Arch Dermatol 132: 285-291, 1996.
17. Lebbé C, de Crémoux P, Millot G et al: Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon. Arch Dermatol Res 289: 421-428, 1997.
18. Reiter Z, Ozes O, Blatt L, Stürzl M, et al: A possible role for interferon alpha and activated natural killer cells in remission of AIDS related Kaposi's sarcoma: in vitro studies. J AIDS 199: 469-476, 1992.
19. Tur E, Brenner S: Classic Kaposi's sarcoma: Low-dose interferon alfa treatment. Dermatology 197: 37-42, 1998.
20. Kovacs JA, Deyton L, Davey R: Combined zidovudine and interferon therapy in patients with Kaposi's sarcoma and acquired immunodeficinecy syndrome. Ann Int Med 1989. 11: 280-287.
21. Hernàndez DE, Pérez JR. Systemic treatment modalities in the managemenet of AIDS-related Kaposi's sarcoma. JEADV 9: 44-49, 1997.
22. Fischl NA. Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma. Am J Med 90: 25-75, 1991.
23. Saiag P, Pavlovic M, Clerici T et al: Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: Results of a sequential npn-randomized phase II trial. AIDA 12: 2139-2176, 1998.
24. Taetle R, Dos Santos B, Akamatsu K, et al: Effects of all-trans retinoic acid and anticeptor antibodies on growth and programmed cell death of human myeloma cells. Clin Cancer Res 2: 253-259, 1995.
25. Musto P, Sajeva MR, Sanpaolo G, et al: All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced myeloma. Haematologica 92: 354-3, 1997.
26. Rady PL, Yen A, Rollefson JL et al: Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 345: 1339-1340, 1995.